首页 | 本学科首页   官方微博 | 高级检索  
     

卡维地洛对糖尿病心肌病病人代谢、炎症反应及心功能的影响
引用本文:肖日军,胡兰,谷铁波,周晓峰. 卡维地洛对糖尿病心肌病病人代谢、炎症反应及心功能的影响[J]. 蚌埠医学院学报, 2021, 46(1): 36-38, 43. DOI: 10.13898/j.cnki.issn.1000-2200.2021.01.010
作者姓名:肖日军  胡兰  谷铁波  周晓峰
作者单位:1.湖南省湘潭市第一人民医院 内分泌科, 4111012.湖南省湘潭市第一人民医院 药学部, 411101
基金项目:湖南省湘潭市医学会科研项目
摘    要:
目的探讨卡维地洛对糖尿病心肌病(DCM)病人代谢、炎症反应及心功能的影响。方法按照随机数字法将180例DCM病人分为对照组88例和观察组92例。对照组病人给予常规治疗,观察组病人在常规治疗的基础上加用卡维地洛(3.125~6.25 mg/d)。治疗12周后,比较2组生化指标[总胆固醇(TC)、三酰甘油(TG)、空腹血糖(FBG)]、炎症指标[超敏C反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)]、心功能指标[左室舒张末期内径(LVEDd)、左室收缩末期前后径(LVEDs)、左室射血分数(LVEF)、氨基末端脑钠肽前体(NT-pro-BNP)、6min步行距离]以及不良反应发生情况。结果治疗后,2组病人的hs-CRP、TNF-α水平均明显下降(P < 0.01),且观察组的hs-CRP、TNF-α水平明显低于对照组(P < 0.01)。治疗后,2组LVEDd、LVEDs及NT-pro BNP水平均明显下降(P < 0.01),LVEF与6min步行距离均明显提高(P < 0.01);且观察组的LVEDd、LVEDs及NT-pro BNP水平明显低于对照组(P < 0.01),LVEF与6min步行距离明显高于对照组(P < 0.01)。2组均未发生严重不良反应导致病例退出研究。对照组发生干咳2例、头痛头晕3例,观察组发生头痛头晕5例、恶心1例,2组不良反应发生情况差异无统计学意义(P>0.05)。结论卡维地洛能够显著改善对DCM病人的炎症状态及心功能,对血脂及血糖无明显影响。

关 键 词:糖尿病心肌病   心功能   炎症反应   卡维地洛
收稿时间:2018-05-30

Impact of carvedilol on the metabolism,inflammatory response and cardiac function of patients with diabetic cardiomyopathy
XIAO Ri-jun,HU Lan,GU Tie-bo,ZHOU Xiao-feng. Impact of carvedilol on the metabolism,inflammatory response and cardiac function of patients with diabetic cardiomyopathy[J]. Journal of Bengbu Medical College, 2021, 46(1): 36-38, 43. DOI: 10.13898/j.cnki.issn.1000-2200.2021.01.010
Authors:XIAO Ri-jun  HU Lan  GU Tie-bo  ZHOU Xiao-feng
Affiliation:1.Department of Endocrinology, The First People's Hospital of Xiangtan City, Xiangtan Hunan 411101, China2.Department of Pharmacy, The First People's Hospital of Xiangtan City, Xiangtan Hunan 411101, China
Abstract:
ObjectiveTo discuss the impacts of carvedilol on metabolism, inflammatory response and cardiac function of patients with diabetic cardiomyopathy(DCM).MethodsOne hundred and eighty DCM patients were divided into the control group(n=88)and observation group(n=92)according to random number method in our hospital.The control group were treated with conventional method, and the observation group were additionally treated with carvedilol(3.125~6.25 mg/d)based on conventional method.After 12 weeks of treatment, the biochemical indexes[including total cholesterol(TC), triglyceride(TG)and fasting blood-glucose(FBG)], inflammation markers[including high-sensitivity C-reactive protein(hs-CRP)and tumour necrosis factor-α(TNF-α)], heart function parameters[including left ventricular end diastolic diamete(LVEDd), left ventricular end-systolic diameter(LVEDs), left ventricular ejection fraction(LVEF), N-terminal pro-brain natriuretic peptid(NT-pro-BNP)and 6mmin walking distance] and adverse reaction were compared between two groups.ResultsAfter treatment, the levels of hs-CRP and TNF-αin two groups significantly decreased(P < 0.01), and the levels of hs-CRP and TNF-α in observation group were significantly lower than those in control group(P < 0.01).After treatment, the levels of LVEDd, LVEDs and NT-pro BNP significantly decreased(P < 0.01), and the LVEF level and 6min walking distance significantly increased in two groups(P < 0.01).After treatment, the levels of LVEDd, LVEDs and NT-pro BNP in observation group were significantly lower than those in control group(P < 0.01), and the LVEF level and 6min walking distance in observation group were significantly higher than those in control group(P < 0.01).No severe adverse reaction occurred in two groups.The dry cough in 2 cases and headache in 3 cases in control group, and dizziness and headache in 5 cases and dizziness and nausea in 1 case in observation group were found, and the difference of the incidence of adverse reactions between two groups was not statistically significant(P>0.05).ConclusionsThe carvedilol can obviously improve the inflammatory state and cardiac function of DCM patients, and there is not significant effect on blood lipid and blood glucose.
Keywords:
本文献已被 万方数据 等数据库收录!
点击此处可从《蚌埠医学院学报》浏览原始摘要信息
点击此处可从《蚌埠医学院学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号